Status:
UNKNOWN
Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
Lead Sponsor:
Paul J. Lamothe
Conditions:
Depressive Disorder,
Treatment-Resistant Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The pur...
Eligibility Criteria
Inclusion
- Age: 18-65 years old
- Mayor Depressive Disorder Diagnosis based on DSM-IV TR.
- Classification of MDD as treatment-resistant.
- No brain structural abnormalities as evidenced by an MRI scan.
- Signed acceptance of Informed Consent.
Exclusion
- Other psychiatric diagnosis apart from MDD.
- Substance abuse or dependence (prior or during study).
- Pregnancy.
- Congestive heart disease.
- Personal history of psychosis.
- First-degree relative with history of psychosis.
- Glaucoma.
- Present neurological disease.
- High blood or pulmonary artery pressure.
- Declining the signing of the informed consent.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01868802
Start Date
September 1 2013
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ABC Neurological Center
Mexico City, Mexico City, Mexico, 05300